Royce & Associates LP maintained its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 627,786 shares of the medical instruments supplier’s stock at the end of the second quarter. Royce & Associates LP owned approximately 1.26% of Merit Medical Systems worth $23,950,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in the company. Municipal Employees Retirement System of Michigan boosted its position in shares of Merit Medical Systems by 1.6% in the first quarter. Municipal Employees Retirement System of Michigan now owns 13,170 shares of the medical instruments supplier’s stock worth $380,000 after buying an additional 210 shares in the last quarter. LS Investment Advisors LLC boosted its position in shares of Merit Medical Systems by 8.1% in the second quarter. LS Investment Advisors LLC now owns 3,694 shares of the medical instruments supplier’s stock worth $141,000 after buying an additional 277 shares in the last quarter. Arizona State Retirement System boosted its position in shares of Merit Medical Systems by 1.3% in the first quarter. Arizona State Retirement System now owns 23,244 shares of the medical instruments supplier’s stock worth $672,000 after buying an additional 300 shares in the last quarter. Louisiana State Employees Retirement System boosted its position in shares of Merit Medical Systems by 1.5% in the second quarter. Louisiana State Employees Retirement System now owns 20,300 shares of the medical instruments supplier’s stock worth $774,000 after buying an additional 300 shares in the last quarter. Finally, Aperio Group LLC boosted its position in shares of Merit Medical Systems by 3.9% in the second quarter. Aperio Group LLC now owns 10,467 shares of the medical instruments supplier’s stock worth $399,000 after buying an additional 391 shares in the last quarter. 89.11% of the stock is currently owned by institutional investors.

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) opened at 40.55 on Tuesday. Merit Medical Systems, Inc. has a 12-month low of $20.70 and a 12-month high of $42.60. The company has a market capitalization of $2.03 billion, a PE ratio of 57.76 and a beta of 1.26. The firm’s 50-day moving average price is $39.88 and its 200-day moving average price is $34.08.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings data on Wednesday, July 26th. The medical instruments supplier reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.07. The firm had revenue of $186.50 million for the quarter, compared to the consensus estimate of $181.46 million. Merit Medical Systems had a net margin of 4.87% and a return on equity of 9.78%. The firm’s revenue was up 23.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.26 earnings per share. On average, analysts expect that Merit Medical Systems, Inc. will post $1.26 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/08/29/royce-associates-lp-has-23950000-stake-in-merit-medical-systems-inc-mmsi.html.

A number of brokerages recently commented on MMSI. Sidoti reaffirmed a “buy” rating and issued a $46.00 target price (up from $41.00) on shares of Merit Medical Systems in a report on Wednesday, June 28th. Craig Hallum reaffirmed a “buy” rating and issued a $50.00 target price (up from $42.00) on shares of Merit Medical Systems in a report on Thursday, July 27th. Bank of America Corporation began coverage on Merit Medical Systems in a report on Thursday, July 20th. They issued a “buy” rating and a $44.00 target price on the stock. UBS AG cut Merit Medical Systems from a “strong-buy” rating to an “outperform” rating in a report on Monday. Finally, Raymond James Financial, Inc. reaffirmed an “outperform” rating and issued a $44.00 target price on shares of Merit Medical Systems in a report on Monday. One investment analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the stock. Merit Medical Systems has a consensus rating of “Buy” and a consensus price target of $40.52.

In related news, Director Kent W. Stanger sold 7,400 shares of the business’s stock in a transaction dated Tuesday, August 8th. The shares were sold at an average price of $42.22, for a total transaction of $312,428.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Richard W. Edelman sold 29,000 shares of the business’s stock in a transaction dated Tuesday, August 1st. The stock was sold at an average price of $41.19, for a total transaction of $1,194,510.00. Following the sale, the insider now directly owns 35,000 shares in the company, valued at approximately $1,441,650. The disclosure for this sale can be found here. In the last three months, insiders have sold 98,250 shares of company stock worth $3,932,799. 5.00% of the stock is owned by insiders.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Stock Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related stocks with our FREE daily email newsletter.